State of Wyoming’s Global Blood Therapeutics, Inc. GBT Stock Holding History

State of Wyoming’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-282	Closed	-$9K	–	2106
2022 Q2	$9K	Buy	282 +68	+32%	+$1.99K	0.01%	1667
2022 Q1	$7K	Buy	214 +41	+24%	+$1.23K	﹤0.01%	1645
2021 Q4	$5K	Sell	173 -9	-5%	-$279	﹤0.01%	1728
2021 Q3	$5K	Sell	182 -88	-33%	-$2.59K	﹤0.01%	1103
2021 Q2	$9K	Buy	270 +234	+650%	+$9.14K	0.01%	1029
2021 Q1	$1K	Buy	+36	New	+$1.66K	﹤0.01%	506

Other funds holding GBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State of Wyoming's GBT Position: Q3 2022 in Review

State of Wyoming sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 282 shares — an estimated $9K sold.

State of Wyoming first reported a position in GBT in Q1 2021 and held it in 6 quarters. The position peaked at $9K in Q2 2022. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

State of Wyoming reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 282 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $9K.
State of Wyoming first reported a position in Global Blood Therapeutics, Inc. in Q1 2021 and held it in 6 quarters.
State of Wyoming's Global Blood Therapeutics, Inc. position peaked at $9K in Q2 2022.
247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.